191658-29-4

Basic information

• Product Name: [4-(4-benzyloxyphenoxy)phenyl]acetic acid
• Synonyms: [4-(4-benzyloxyphenoxy)phenyl]acetic acid
• CAS NO: 191658-29-4
• Molecular Weight: 334.372
• Mol File: 191658-29-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: [4-(4-benzyloxyphenoxy)phenyl]acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(4-benzyloxyphenoxy)phenyl]acetic acid(191658-29-4)
• EPA Substance Registry System: [4-(4-benzyloxyphenoxy)phenyl]acetic acid(191658-29-4)

Safety Data

• Hazardous Substances Data: 191658-29-4(Hazardous Substances Data)

Upstream product

• 500-79-8 [4-(4-hydroxyphenoxy)phenyl]acetic acid 
• 100-39-0 benzyl bromide 
• 67-56-1 methanol 
• 103-16-2 4-Benzyloxyphenol 
• 41841-16-1 (4-bromo-phenyl)-acetic acid methyl ester 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 257609-02-2 1-(4-(4-(benzyloxy)phenoxy)phenyl)ethan-1-one 
• 257609-05-5 2-(4-(4-benzyloxyphenoxy)phenyl)-1-morpholin-4-yl-ethanethione 

Downstream Products

• 257609-42-0 2-(2-(4-(4-Benzyloxyphenoxy)phenyl)acetylamino)benzoic acid methyl ester 
• 852631-22-2 5-[4-(4-benzyloxyphenoxy)phenyl]pyrimidine-2,4,6-trione 
• 852631-18-6 [4-(4-benzyloxyphenoxy)phenyl]malonic acid dimethyl ester 
• 852631-14-2 [4-(4-benzyloxyphenoxy)phenyl]acetic acid methyl ester 

Relevant articles and documents

C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging

Studies have demonstrated a positive correlation between inflammation, metastasis, or atherosclerosis and the unbalanced or culminated expression of matrix metalloproteinases (MMPs). The molecular imaging of locally upregulated MMP activity in vivo is a c

Cancer remedy comprising anthranilic acid derivatives as active ingredients

A cancer remedy comprising a compound represented by the following formula as an active ingredient: wherein, X represents a group represented by either of the following formulae: wherein, R1 and R2 represent each a hydrogen atom, a h